Evidence map›Paper›PMID 35304084›Full record

Observational studyOral surgery, oral medicine, oral pathology and oral radiology2022

Radiation therapy for head and neck cancer leads to gingival recession associated with dental caries.

Rajesh V Lalla, Nathaniel S Treister, Thomas P Sollecito, Brian L Schmidt, Lauren L Patton, Erika S Helgeson, Alexander Lin, Cynthia Rybczyk, Robert Dowsett, Upendra Hegde and 3 more

3 registry-linked trialsOpen access · greenAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Oral surgery, oral medicine, oral pathology and oral radiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02057510 completednot on this map

Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients

Typeobservational_patient_registrySponsorWake Forest University Health SciencesRan2014 to 2020Enrolled613ConditionsHead and Neck Cancer, Dental Disease, Xerostomia, Osteoradionecrosis
NCT06481059 completednot on this map

Soluble Urokinase Plasminogen Activator Receptor (suPAR) is a Potential Biomarker of Stage III-IV, Grade C Periodontitis Through the Impact of Post-radiotherapy on Head and Neck Cancer Patients

TypeobservationalSponsorAl-Maarif University CollegeRan2022 to 2023Enrolled150ConditionsHead and Neck Cancer, Chronic Periodontitis, Radiotherapy, ComplicationsArmsHead and Neck cancer post-radiotherapy
NCT06529588 completednot on this map

Soluble Urokinase Plasminogen Activator Receptor (suPAR) is a Potential Biomarker of Stage III-IV, Grade C Periodontitis Through the Impact of Post-radiotherapy on Head and Neck Cancer Patients

TypeobservationalSponsorAl-Maarif University CollegeRan2022 to 2023Enrolled150ConditionsHead and Neck Cancer, Chronic Periodontitis, Radiotherapy Side EffectArmsRadiation
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Chronic Oral Complications of Oral Cancer Therapy.Dental clinics of North America · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 10 institutions in 1 country.

Rajesh V LallaSection of Oral Medicine, University of Connecticut Health, Farmington, CT, USA. Electronic address: Lalla@uchc.edu.
Nathaniel S TreisterDivision of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA, USA; Department of Oral Medicine, Infection and Immunity, Harvard School of Dental Medicine, MA, USA.
Thomas P SollecitoDepartment of Oral Medicine, University of Pennsylvania School of Dental Medicine, Philadelphia, PA, USA; Division of Oral Medicine, University of Pennsylvania Health System, Philadelphia, PA, USA.
Brian L SchmidtDepartment of Oral and Maxillofacial Surgery and Bluestone Center for Clinical Research, New York University College of Dentistry, New York, NY, USA.
Lauren L PattonDivision of Craniofacial and Surgical Care, Adams School of Dentistry, University of North Carolina, Chapel Hill, NC, USA.
Erika S HelgesonDivision of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
Alexander LinDepartment of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
Cynthia RybczykSection of Oral Medicine, University of Connecticut Health, Farmington, CT, USA.
Robert DowsettDivision of Radiation Oncology, University of Connecticut Health, Farmington, CT, USA.
Upendra HegdeDivision of Medical Oncology, University of Connecticut Health, Farmington, CT, USA.
Timothy S BoydDepartment of Radiation Oncology, Hartford Hospital, Hartford, CT, USA.
Thomas G DuplinskyDepartment of Dentistry, Yale New Haven Hospital, New Haven, CT, USA.
Michael T BrennanDepartment of Oral Medicine, Atrium Health Carolinas Medical Center, Charlotte, NC, USA.
UConn Health · USCarolinas Medical Center · USHartford Financial Services (United States)Harvard University · USNew York University · USUniversity of Minnesota · USUniversity of North Carolina at Chapel Hill · USUniversity of Pennsylvania · USUniversity of Pennsylvania Health System · USYale New Haven Hospital · US

Funding

Long-term Oral Complications of an Established Head and Neck Cancer Cohort- Clinical Registry of Dental Outcomes in Head and Neck Cancer Patients: OraRadU01DE022939 · NIDCR · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BRENNAN, MICHAEL T, LALLA, RAJESH V. · 2012 to 2023
$16.8M
NIDCR NIH HHS U01 DE022939
6 · The paper itself

Abstract

objectiveThe aim of this study was to examine effects of radiation therapy (RT) for head and neck cancer (HNC) on periodontal disease and relationships to caries. STUDY

designA multicenter prospective observational cohort study (OraRad) was conducted in patients undergoing RT for HNC. Assessments were conducted by calibrated examiners at the pre-RT (baseline) visit (n = 533), the 12-month visit (n = 414), and the 24-month visit (n = 365).

resultsThe average whole mouth mean (standard error (SE)) distance from the cementoenamel junction to the gingival margin (CEJ-GM) decreased significantly from 0.43 (0.04) mm at baseline to 0.24 (0.04) mm at 12 months and 0.11 (0.04) mm at 24 months (P ≤ .001). Whole mouth mean (SE) percentage of sites with CEJ-GM distance of <0 mm increased significantly from 23.3% (1.0%) at baseline to 28.5% (1.0%) at 12 months and 30.5% (1.1%) at 24 months (P ≤ .02). Higher mean radiation dose to the mandible was associated with a greater increase in the percentage of mandibular sites with CEJ-GM distance of <0 mm (P = .003). Both mean CEJ-GM distance and the percentage of sites with a CEJ-GM distance <0 mm were strongly associated with whole mouth mean proportion of decayed, missing, and filled surfaces, as well as proportion of decayed or filled facial/buccal surfaces specifically, (P < .001), with greater gingival recession associated with increased caries.

conclusionsRT for HNC leads to mandibular gingival recession in a dose-dependent manner. This gingival recession may contribute to increased risk for cervical caries seen in these patients.

Indexed as

Dental CariesGingival RecessionHead and Neck NeoplasmsHumansProspective StudiesTooth Cervix

Identifiers

PMID35304084
PMCPMC9018549
OpenAlexW4210812015

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.